In both groups, the vast majority had breast cancer diagnosis, with only two cases of ovarian cancer (one with a mutation in each BRCA gene, both novel variants) and two cases with both breast and ovary cancers (both with a mutation in BRCA2), all of them in the novel variant group (Table 2). This evidence concerns the gene BRCA2 and breast cancer.